Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 906086, 6 pages
http://dx.doi.org/10.1155/2015/906086
Research Article

Cyclic AMP-Responsive Element Modulator α Polymorphisms Are Potential Genetic Risks for Systemic Lupus Erythematosus

Department of Rheumatology & Immunology, Peking University People’s Hospital, 11 Xizhimen South Street, Beijing 100044, China

Received 17 June 2015; Revised 23 September 2015; Accepted 5 October 2015

Academic Editor: Fulvia Ceccarelli

Copyright © 2015 Qian Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Rapoport and O. Bloch, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 366, no. 6, p. 574, 2012. View at Google Scholar · View at Scopus
  2. L. A. Criswell, K. A. Pfeiffer, R. F. Lum et al., “Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes,” American Journal of Human Genetics, vol. 76, no. 4, pp. 561–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-L. Liu, F.-Y. Zhang, Y.-H. Liang et al., “Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 4, pp. 425–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Cui, Y. Sheng, and X. Zhang, “Genetic susceptibility to SLE: recent progress from GWAS,” Journal of Autoimmunity, vol. 41, pp. 25–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Crispín, C. M. Hedrich, and G. C. Tsokos, “Gene-function studies in systemic lupus erythematosus,” Nature Reviews Rheumatology, vol. 9, no. 8, pp. 476–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Tenbrock, Y.-T. Juang, N. Leukert, J. Roth, and G. C. Tsokos, “The transcriptional repressor cAMP response element modulator α interacts with histone deacetylase 1 to repress promoter activity,” The Journal of Immunology, vol. 177, no. 9, pp. 6159–6164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Tenbrock, V. C. Kyttaris, M. Ahlmann et al., “The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain,” Journal of Immunology, vol. 175, no. 9, pp. 5975–5980, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Rauen, K. Benedyk, Y.-T. Juang et al., “A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus,” Journal of Biological Chemistry, vol. 286, no. 37, pp. 32366–32372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-T. Juang, T. Rauen, Y. Wang et al., “Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus,” The Journal of Biological Chemistry, vol. 286, no. 3, pp. 1795–1801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. V. C. Kyttaris, Y. Wang, Y.-T. Juang, A. Weinstein, and G. C. Tsokos, “CAMP response element modulator α expression in patients with systemic lupus erythematosus,” Lupus, vol. 15, no. 12, pp. 840–844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  12. C. A. Anderson, G. Boucher, C. W. Lees et al., “Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47,” Nature Genetics, vol. 43, no. 3, pp. 246–252, 2011. View at Publisher · View at Google Scholar
  13. A. Franke, D. P. McGovern, J. C. Barrett et al., “Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci,” Nature Genetics, vol. 42, no. 12, pp. 1118–1125, 2010. View at Publisher · View at Google Scholar
  14. L. A. Hindorff, P. Sethupathy, H. A. Junkins et al., “Potential etiologic and functional implications of genome-wide association loci for human diseases and traits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 23, pp. 9362–9367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. G. Katsiari and G. C. Tsokos, “Transcriptional repression of interleukin-2 in human systemic lupus erythematosus,” Autoimmunity Reviews, vol. 5, no. 2, pp. 118–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-T. Juang, Y. Wang, E. E. Solomou et al., “Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 996–1005, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Hedrich, T. Rauen, and G. C. Tsokos, “cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus,” The Journal of Biological Chemistry, vol. 286, no. 50, pp. 43429–43436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Lenardo, “lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis,” Nature, vol. 353, no. 6347, pp. 858–861, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Linker-Israeli, A. C. Bakke, R. C. Kitridou, S. Gendler, S. Gillis, and D. A. Horwitz, “Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE),” Journal of Immunology, vol. 130, no. 6, pp. 2651–2655, 1983. View at Google Scholar · View at Scopus
  20. A. La Cava, “Regulatory immune cell subsets in autoimmunity,” Autoimmunity, vol. 44, no. 1, pp. 1–2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Kovacs, D. E. Thomas, and G. C. Tsokos, “Elevated in vivo expression of the costimulatory molecule B7-BB1 (CD80) on antigen presenting cells from a patient with SLE,” Clinical & Experimental Rheumatology, vol. 14, no. 6, pp. 695–697, 1996. View at Google Scholar · View at Scopus
  22. D. Gómez-Martín, M. Díaz-Zamudio, J. C. Crispín, and J. Alcocer-Varela, “Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities,” Autoimmunity Reviews, vol. 9, no. 1, pp. 34–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-M. Chen, C. Férec, and D. N. Cooper, “A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview,” Human Genetics, vol. 120, no. 1, pp. 1–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Löfgren, A. M. Delgado-Vega, C. J. Gallant et al., “A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 62, no. 11, pp. 3404–3414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Galeazzi, G. D. Sebastiani, G. Morozzi et al., “HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets,” Medicine, vol. 81, no. 3, pp. 169–178, 2002. View at Publisher · View at Google Scholar